Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Minimum clinically important improvement"'
Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis
Autor:
Vinod K. Gupta, Kevin Y. Cunningham, Benjamin Hur, Utpal Bakshi, Harvey Huang, Kenneth J. Warrington, Veena Taneja, Elena Myasoedova, John M. Davis, Jaeyun Sung
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-20 (2021)
Abstract Background Rapid advances in the past decade have shown that dysbiosis of the gut microbiome is a key hallmark of rheumatoid arthritis (RA). Yet, the relationship between the gut microbiome and clinical improvement in RA disease activity rem
Externí odkaz:
https://doaj.org/article/fbd00a95259145969ce1d6e0669a5c9c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zuschmidt, Benjamin
Introduction: low back pain and sciatica are a major public health problems. This has become a priority since the past decades. The Discogel, percutaneously administrated, is used for the treatment of lumbar sciatica or low back pain caused by a hern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::ea506ac3ddf6f05917cfc2ae7515476a
https://dumas.ccsd.cnrs.fr/dumas-02435739
https://dumas.ccsd.cnrs.fr/dumas-02435739
Autor:
Milla Johanna Kviatkovsky, Marc C. Hochberg, Florence Tubach, Nicholas Bellamy, David T. Felson, Claire Bombardier, marco Matucci-Cerinic, Désirée van der Heijde, Mazime Dougados, Robert Landewe, Isabelle Logeart, Emilio Martín-Mola, Hassane Awada, Mart van der Laar, Najia Hajjaj-Hassouni, Philippe Ravaud, Sofia Ramiro
Publikováno v:
Journal of Rheumatology, 43(9), 1680-1686
Kviatkovsky, M J, Ramiro, S, Landewe, R, Dougados, M, Tubach, F, Bellamy, N, Hochberg, M, Ravaud, P, Martin-Mola, E, Awada, H, Bombardier, C, Felson, D, Hajjaj-Hassouni, N, Logeart, I, Matucci-Cerinic, M, van der Laar, M & van der Heijde, D 2016, ' The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis ', The Journal of rheumatology, vol. 43, no. 9, pp. 1680-1686 . https://doi.org/10.3899/jrheum.151244
Kviatkovsky, M J, Ramiro, S, Landewe, R, Dougados, M, Tubach, F, Bellamy, N, Hochberg, M, Ravaud, P, Martin-Mola, E, Awada, H, Bombardier, C, Felson, D, Hajjaj-Hassouni, N, Logeart, I, Matucci-Cerinic, M, van der Laar, M & van der Heijde, D 2016, ' The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis ', The Journal of rheumatology, vol. 43, no. 9, pp. 1680-1686 . https://doi.org/10.3899/jrheum.151244
Objective.To establish cutoffs for the minimum clinically important improvement (MCII) and the patient-acceptable symptom state (PASS) for the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd1c892b2b9dcf3f52a9d1b6fe5a5ebd
https://hdl.handle.net/1887/112367
https://hdl.handle.net/1887/112367
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.